SE396755B - Sett att bereda en platinaforening med koordinerad bindning - Google Patents

Sett att bereda en platinaforening med koordinerad bindning

Info

Publication number
SE396755B
SE396755B SE7305077A SE7305077A SE396755B SE 396755 B SE396755 B SE 396755B SE 7305077 A SE7305077 A SE 7305077A SE 7305077 A SE7305077 A SE 7305077A SE 396755 B SE396755 B SE 396755B
Authority
SE
Sweden
Prior art keywords
platinum
association
prepare
way
coordinated binding
Prior art date
Application number
SE7305077A
Other languages
English (en)
Inventor
M L Tobe
A R Khokhar
P D M Braddock
Original Assignee
Rustenburg Platinum Mines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rustenburg Platinum Mines Ltd filed Critical Rustenburg Platinum Mines Ltd
Publication of SE396755B publication Critical patent/SE396755B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7305077A 1972-04-10 1973-04-10 Sett att bereda en platinaforening med koordinerad bindning SE396755B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1645172A GB1432563A (en) 1972-04-10 1972-04-10 Platinum- co-ordination compounds
GB2139072 1972-05-08

Publications (1)

Publication Number Publication Date
SE396755B true SE396755B (sv) 1977-10-03

Family

ID=26252050

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7305077A SE396755B (sv) 1972-04-10 1973-04-10 Sett att bereda en platinaforening med koordinerad bindning

Country Status (7)

Country Link
US (1) US3904663A (sv)
JP (1) JPS535369B2 (sv)
DE (1) DE2318021A1 (sv)
FR (1) FR2182942B1 (sv)
GB (1) GB1432563A (sv)
NL (1) NL7304881A (sv)
SE (1) SE396755B (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419340A (en) * 1969-03-24 1983-12-06 University Of Delaware Controlled release of anticancer agents from biodegradable polymers
GB1578323A (en) * 1976-02-26 1980-11-05 Rustenburg Platinum Mines Ltd Compositions containing platinum
GB1585103A (en) * 1976-04-06 1981-02-25 Rustenburg Platinum Mines Ltd Pharmaceutical compositions containing platinum compounds
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
US4278660A (en) * 1977-05-02 1981-07-14 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4151185A (en) * 1977-05-02 1979-04-24 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4137248A (en) * 1977-08-29 1979-01-30 The United States Of America As Represented By The Department Of Health, Education And Welfare Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
US4203912A (en) * 1977-10-19 1980-05-20 Johnson, Matthey & Co., Limited Compositions containing platinum
SE447385B (sv) * 1977-10-19 1986-11-10 Johnson Matthey Co Ltd Cis-koordinationsforeningar av platina
SE447902B (sv) * 1977-10-19 1986-12-22 Johnson Matthey Co Ltd Cis-koordinationsforening av platina och komposition innehallande foreningen
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
US4405757A (en) * 1979-09-14 1983-09-20 Howell Bobby A Macromolecular complexes of amidocarbonylic water-soluble polymers and square planar platinous and equivalent organometallics
US4578491A (en) * 1982-06-28 1986-03-25 Engelhard Corporation Bis(thiocyanato)palladium(II) complexes
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
IL71804A (en) * 1983-05-10 1989-06-30 Andrulis Res Corp Bis-(platinum diamine)complexes and antitumor pharmaceutical compositions containing the same
US4544759A (en) * 1983-07-29 1985-10-01 American Cyanamid Company Platinum complexes of antitumor agents
US4588831A (en) * 1984-11-09 1986-05-13 Natec Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
CZ2002895A3 (cs) * 1999-09-14 2003-01-15 Smithkline Beecham Corporation Závěrný systém nádoby
WO2001036431A1 (en) 1999-11-15 2001-05-25 Parker Hughes Institute Diamino platinum (ii) antitumor complexes
JP2007502777A (ja) 2003-08-13 2007-02-15 ユニバーシティー オブ サウス フロリダ 腫瘍の処置のための白金錯体
US20050288365A1 (en) * 2004-01-06 2005-12-29 Heidi Kay Platinum complexes and methods for inhibiting tumor cell proliferation
WO2007008247A2 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
WO2007006019A1 (en) * 2005-07-06 2007-01-11 University Of South Florida Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression
JP5378792B2 (ja) 2006-06-28 2013-12-25 株式会社Ihi 磁性薬誘導システム
JP4774536B2 (ja) * 2006-11-06 2011-09-14 株式会社Ihi 磁性材料、磁性材料の誘導装置及び磁性材料の設計方法
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
RU2495045C2 (ru) 2008-11-20 2013-10-10 АйЭйчАй КОРПОРЕЙШН Комплексное соединение самонамагничивающегося металла с саленом
EP3327148B1 (en) 2010-06-18 2021-03-17 Myriad Genetics, Inc. Methods of predicting the status of brca1 and brca2 genes in a cancer cell
DK3109325T3 (en) 2010-08-24 2019-01-28 Dana Farber Cancer Inst Inc Methods for predicting anticancer response
CA2839210A1 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
BR112014015152A2 (pt) 2011-12-21 2017-07-04 Myriad Genetics Inc métodos e materiais para a avaliação da perda de heterozigosidade
CA3080441A1 (en) 2012-02-23 2013-09-06 The Children's Hospital Corporation Methods for predicting anti-cancer response
US11091808B2 (en) 2012-06-07 2021-08-17 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
EP2981624B1 (en) 2013-04-05 2019-12-18 Myriad Genetics, Inc. Methods for assessing homologous recombination deficiency and predicting response to cancer treatment
EP3080292B1 (en) 2013-12-09 2022-02-02 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
AU2015301390B2 (en) 2014-08-15 2021-08-26 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
EP4141127A1 (en) 2021-08-30 2023-03-01 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Also Published As

Publication number Publication date
US3904663A (en) 1975-09-09
FR2182942B1 (sv) 1976-10-22
NL7304881A (sv) 1973-10-12
FR2182942A1 (sv) 1973-12-14
GB1432563A (en) 1976-04-22
DE2318021A1 (de) 1973-11-08
JPS535369B2 (sv) 1978-02-27
JPS4913317A (sv) 1974-02-05

Similar Documents

Publication Publication Date Title
SE396755B (sv) Sett att bereda en platinaforening med koordinerad bindning
SE415182B (sv) Sett att framstella platinakoordinationsforeningar
BE808993A (fr) Perfectionnements relatifs a des elements de construction
SE386309B (sv) Sett att tillverka en transistor
SE417089B (sv) Sett att framstella en sulfonamidoarylforening
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE417982B (sv) Sett att framstella cefalosporinforeningar
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE8205332D0 (sv) Sett att framstella hoghallfast stalband
SE387563B (sv) Sett att framstella en vevaxel
SE382215B (sv) Sett att framstella kromanderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE381651B (sv) Sett att framstella karbamater
SE381257B (sv) Sett att framstella rifamycinderivat
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE405966B (sv) Sett att framstella peptider
SE400078B (sv) Sett att framstella kinazolinonderivat
SE7505549L (sv) Sett att framstella kaffearommaterial.
SE397679B (sv) Sett att framstella kinazolinonderivat
SE389443B (sv) Sett att framstella en fergad fodoemneskomposition
SE419647B (sv) Sett att framstella tiazolisokinolinderivat